Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

被引：6
|
作者：
Edgell, ET
Andersen, WS
Johnstone, BM
Dulisse, B
Revicki, D
Breier, A
Gavart, S
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Medtap Int, Bethesda, MD USA
来源：
EUROPEAN PSYCHIATRY | 2000年 / 15卷
关键词：
D O I：
10.1016/S0924-9338(00)94724-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：408S / 408S
页数：1
相关论文
共 50 条
  • [31] Two year outcomes on risperidone and olanzapine in stable patients with schizophrenia
    Marder, Stephen R.
    Noordsy, Douglas L.
    Glynn, Shirley M.
    O'Keefe, Christopher
    Almeida, Margaret A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S250 - S250
  • [32] Olanzapine versus risperidone in the treatment of schizophrenia: A mental health cost comparison in a managed care setting
    Sommers, S
    Lynch, F
    McFarland, B
    Muilenburg, N
    VALUE IN HEALTH, 2003, 6 (03) : 354 - 355
  • [33] Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia
    Akerele, Evaristo
    Levin, Frances R.
    AMERICAN JOURNAL ON ADDICTIONS, 2007, 16 (04): : 260 - 268
  • [34] Weight gain in Korean schizophrenia inpatients: A comparison of risperidone and olanzapine
    Kim, H
    Lee, KJ
    Lee, SH
    Chung, YC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S255 - S255
  • [35] Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study
    Kasper, S
    Jones, M
    Duchesne, I
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (04) : 189 - 196
  • [36] A comparison of the outcomes and costs of risperidone and olanzapine treatment in The Netherlands
    Loonen, AJM
    Gerdes, JH
    Van Berkestijn, JWBM
    Veefkind, AH
    Kaasenbrood, AJA
    Fouwels, AJ
    Hoogenboom, B
    Weeda, JN
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S283 - S284
  • [37] Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes
    Noordsy, Douglas L.
    Glynn, Shirley M.
    Sugar, Catherine A.
    O'Keefe, Christopher D.
    Marder, Stephen R.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 95 : 299 - 307
  • [38] CHARACTERISTICS OF OUTPATIENTS INITIATED ON OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA IN JAPAN
    Ye, W.
    Nakahara, N.
    Takahashi, M.
    Ascher-Svanum, H.
    VALUE IN HEALTH, 2010, 13 (07) : A554 - A554
  • [39] Health care costs for schizophrenia patients started on olanzapine versus risperidone
    Russo, PA
    Smith, MW
    Namjoshi, M
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (06) : 610 - 615
  • [40] Higher Motor Activity in Schizophrenia Patients Treated With Olanzapine Versus Risperidone
    Walther, Sebastian
    Horn, Helge
    Razavi, Nadja
    Koschorke, Philipp
    Wopfner, Alexander
    Mueller, Thomas J.
    Strik, Werner
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 181 - 184
12345